The global endoscopic submucosal dissection market size was valued at USD 324.7 million in 2023, driven by its increasing acceptance as a pivotal technique in treating early-stage gastrointestinal cancers across the globe. The market size is anticipated to grow at a CAGR of 7.0% during the forecast period of 2024-2032 to achieve a value of USD 594.5 million by 2032.
By making a circumferential incision around the lesion and dissecting the submucosal layer beneath it, ESD ensures minimal damage to the surrounding healthy tissue. This technique has gained significant traction for its ability to treat early gastrointestinal cancers, particularly those in the stomach, oesophagus, and colon, with a lower risk of recurrence. Its minimally invasive nature, reduced hospitalization times, and potential to spare patients from more extensive surgeries make ESD a preferred choice in appropriate clinical scenarios. However, it demands advanced endoscopic skills and expertise, given its technical complexity and risk of potential complications.
As the demand for minimally invasive surgeries swells, the preference for ESD over more invasive surgical options is palpable, leading to shorter hospital stays and improved patient recovery profiles. Training and education have surged as pivotal focal points, with medical institutions and device manufacturers investing in programs to upskill endoscopists, addressing the procedure's technical challenges. However, the market's growth is juxtaposed with concerns about procedure-related complications, emphasizing the continuous refinement of techniques and tools. In essence, the global ESD market is defined by its commitment to innovation, skill development, and the overarching goal of elevating patient outcomes in gastrointestinal oncology.
The technical complexity of ESD necessitates advanced training and expertise, leading to a surge in dedicated training programs and workshops worldwide. This emphasis on skill development ensures that the benefits of the procedure are harnessed while minimizing potential complications. In summation, the global ESD market, thriving on innovation and education, is steadily establishing itself as a cornerstone in minimally invasive gastrointestinal oncology interventions.
This product will be delivered within 5-7 business days.
Endoscopic Submucosal Dissection: Introduction
Endoscopic Submucosal Dissection (ESD) is a sophisticated endoscopic procedure developed primarily in Asia, aiming to remove gastrointestinal neoplasms in one piece, ensuring clear histological assessment. Unlike traditional endoscopic mucosal resection, which is suitable for smaller lesions, ESD allows for the en bloc resection of larger lesions without size restrictions.By making a circumferential incision around the lesion and dissecting the submucosal layer beneath it, ESD ensures minimal damage to the surrounding healthy tissue. This technique has gained significant traction for its ability to treat early gastrointestinal cancers, particularly those in the stomach, oesophagus, and colon, with a lower risk of recurrence. Its minimally invasive nature, reduced hospitalization times, and potential to spare patients from more extensive surgeries make ESD a preferred choice in appropriate clinical scenarios. However, it demands advanced endoscopic skills and expertise, given its technical complexity and risk of potential complications.
Key Trends in the Global Endoscopic Submucosal Dissection Market
The global endoscopic submucosal dissection (ESD) market is being sculpted by several influential trends. Foremost is the expanding adoption of ESD as a primary intervention for early-stage gastrointestinal cancers, fueled by its superior efficacy in enabling en bloc resections and reducing recurrence rates. This is complemented by technological advancements in endoscopic tools and devices, enhancing precision and safety during procedures.As the demand for minimally invasive surgeries swells, the preference for ESD over more invasive surgical options is palpable, leading to shorter hospital stays and improved patient recovery profiles. Training and education have surged as pivotal focal points, with medical institutions and device manufacturers investing in programs to upskill endoscopists, addressing the procedure's technical challenges. However, the market's growth is juxtaposed with concerns about procedure-related complications, emphasizing the continuous refinement of techniques and tools. In essence, the global ESD market is defined by its commitment to innovation, skill development, and the overarching goal of elevating patient outcomes in gastrointestinal oncology.
Global Endoscopic Submucosal Dissection Market Segmentation
Market Breakup by Type
- Grasp
- Clips
- Gastroscopes
- Colonoscopes
Market Breakup by Indications
- Stomach Cancer
- Colon Cancer
Market Breakup by End User
- Hospitals,
- Ambulatory Surgical Centres
- Specialty Clinics
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Endoscopic Submucosal Dissection Market Overview
The global endoscopic submucosal dissection (ESD) market is witnessing a robust expansion, driven by its increasing acceptance as a pivotal technique in treating early-stage gastrointestinal cancers. As the medical community becomes more acquainted with the benefits of en bloc resections offered by ESD, particularly in reducing recurrence rates, its preference over traditional methods is on the rise. Technological advancements play a cardinal role, with state-of-the-art endoscopic devices being introduced to improve the precision, safety, and overall efficacy of the procedure. However, the market's trajectory isn't devoid of challenges.The technical complexity of ESD necessitates advanced training and expertise, leading to a surge in dedicated training programs and workshops worldwide. This emphasis on skill development ensures that the benefits of the procedure are harnessed while minimizing potential complications. In summation, the global ESD market, thriving on innovation and education, is steadily establishing itself as a cornerstone in minimally invasive gastrointestinal oncology interventions.
Global Endoscopic Submucosal Dissection Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:- Olympus Corporation
- Boston Scientific Corporation
- FUJIFILM Holdings Corporation
- T Sumitomo Bakelite Co., Ltd.
- Creo Medical
- Medtronic plc
- HOYA Corporation
- Ovesco Endoscope AG
- ConMed Corporation
- A Steris PLC
This product will be delivered within 5-7 business days.
Table of Contents
1 Preface
3 Global Endoscopic Submucosal Dissection Market Overview
4 Global Endoscopic Submucosal Dissection Market Landscape
5 Global Endoscopic Submucosal Dissection Market Dynamics
6 Global Endoscopic Submucosal Dissection Market Segmentation
7 North America Endoscopic Submucosal Dissection Market
8 Europe Endoscopic Submucosal Dissection Market
9 Asia Pacific Endoscopic Submucosal Dissection Market
10 Latin America Endoscopic Submucosal Dissection Market
11 Middle East and Africa Endoscopic Submucosal Dissection Market
12 Regulatory Framework
13 Funding and Investment Analysis
14 Partnership and Collaborations Analysis
15 Supplier Landscape
17 Company Competitiveness Analysis (Additional Insight)
18 Payment Methods (Additional Insight)
Companies Mentioned
- Olympus Corporation
- Boston Scientific Corporation FUJIFILM Holdings Corporation
- T Sumitomo Bakelite Co. Ltd.
- Creo Medical
- Medtronic plc
- HOYA Corporation
- Ovesco Endoscope AG
- ConMed Corporation
- A Steris PLC
Methodology
LOADING...